Jon Cunningham (@jonwcunningham) 's Twitter Profile
Jon Cunningham

@jonwcunningham

Heart Failure Cardiologist & Investigator, @BrighamWomens @harvardmed @broadinstitute
AI to Improve Cardiovascular Clinical Trials & Care

ID: 959385909815803904

linkhttps://connects.catalyst.harvard.edu/Profiles/display/Person/89848 calendar_today02-02-2018 11:20:00

412 Tweet

939 Takipçi

505 Takip Edilen

Emily Lau, MD, MPH (@emilyswlau) 's Twitter Profile Photo

"Just as we’re making progress in the fight against women’s heart disease, these cuts ...are a knockout blow to women’s heart health." As a women's cardiologist and researcher, these words are powerful and cut deep. Read 👉: bit.ly/3QqbLQ2 Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Women's Heart Alliance

Emily Lau, MD, MPH (@emilyswlau) 's Twitter Profile Photo

Elegant study in Circulation Research examining endothelial function in post-menopausal 👭 with late onset menopause. Editorial led by 🌟 @brighamfellows Gurleen Kaur, MD discusses unanswered questions for future investigation to better understand the link between menopause and🫀disease.

HF Collaboratory (@hfcollaboratory) 's Twitter Profile Photo

What a great Special Focus meeting 🎉 We took polls after our presenters Dr. Milton Packer & Javed Butler presented both for and against the necessity of maximized GDMT in HF drug & device development Results below ⬇️ feel free to answer the poll in our previous post!

What a great Special Focus meeting 🎉

We took polls after our presenters Dr. Milton Packer &amp; <a href="/JavedButler1/">Javed Butler</a> presented both for and against the necessity of maximized GDMT in HF drug &amp; device development

Results below ⬇️ 

feel free to answer the poll in our previous post!
Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

#ACC25 has officially kicked off! Incredibly fortunate to learn from these superstar colleagues at the BWH Clinical Trials Outcomes Center 🔥 Showcasing 15 new analyses from 12 trials/registries, including 5 simultaneous publications, spanning #CKM topics See you in Chicago!

#ACC25 has officially kicked off!

Incredibly fortunate to learn from these superstar colleagues at the BWH Clinical Trials Outcomes Center

🔥 Showcasing 15 new analyses from 12 trials/registries, including 5 simultaneous publications, spanning #CKM topics

See you in Chicago!
HF Collaboratory (@hfcollaboratory) 's Twitter Profile Photo

Our speakers are primed and ready for the HFC Spring Working Group and Think Tank Meeting this Friday, April 11, 2025. Secure your spot by registering now: hfcollaboratory.com/meetings/sprin… #hfc #heartfailurecollaboratory #heartfailure #cardiology

HF Collaboratory (@hfcollaboratory) 's Twitter Profile Photo

Hear directly from our members as they share why #HFC plays a vital role in shaping the future of #heartfailure #research & care. From improving #clinicaltrials to fostering collabs across sectors, HFC is where progress begins. #cardiotwitter #heartfailurecollaboratory #Cardio

Jon Cunningham (@jonwcunningham) 's Twitter Profile Photo

In JACC Journals #JACCHF, Christopher O'Connor and share our vision for "The Future of AI-Assisted Event Adjudication" AI adjudication may provide the consistency of a CEC without expense & delays jacc.org/doi/10.1016/j.…

Ankeet S. Bhatt, MD, MBA (@ankeetbhatt) 's Twitter Profile Photo

Rationale, Design, and Baseline char. of KP-VACCINATE out in AmericanHeartJ. ~3.8 Million adults randomized in 2 integrated learning healthcare systems in ~4 weeks. To our knowledge, the 🌟largest RCT ever🌟 & fully embedded in routine case. Results soon sciencedirect.com/science/articl…

Rationale, Design, and Baseline char. of KP-VACCINATE out in <a href="/AmericanHeartJ/">AmericanHeartJ</a>. ~3.8 Million adults randomized in 2 integrated learning healthcare systems in ~4 weeks. To our knowledge, the 🌟largest RCT ever🌟 &amp; fully embedded in routine case. Results soon sciencedirect.com/science/articl…
Rohan Khera (@rohan_khera) 's Twitter Profile Photo

Excited that #PanEcho is now published in JAMA Kudos to Greg Holste Evangelos K. Oikonomou for leading this incredible effort! Now also validated on ED POCUS studies + RVNet+ (Thx Attila Kovacs & Marton Tokodi for joining us) See 🧵 below for details! jamanetwork.com/journals/jama/…

Excited that #PanEcho is now published in <a href="/JAMA_current/">JAMA</a> 

Kudos to <a href="/giholste/">Greg Holste</a> <a href="/ekoikonomou/">Evangelos K. Oikonomou</a> for leading this incredible effort!

Now also validated on ED POCUS studies + RVNet+ (Thx Attila Kovacs &amp; Marton Tokodi for joining us)

See 🧵 below for details! 
jamanetwork.com/journals/jama/…
Jon Cunningham (@jonwcunningham) 's Twitter Profile Photo

Aldosterone synthase inhibitors offer an alternative strategy to target a classic pathway in hypertension, renal, and CV disease In Med by Cell Press, Carolyn Lam and I review recent ASI trials in hypertension and future evaluation in HF & CKD authors.elsevier.com/c/1lPvv9UKeTpc…

Pierre Elias, MD (@pierreeliasmd) 's Twitter Profile Photo

🧵1/Today, we published a key milestone towards AI based cardiac screening in Nature. doi.org/10.1038/s41586… EchoNext outperformed cardiologists and found thousands of high-risk patients missed in routine care. We also made a version available to the world.

🧵1/Today, we published a key milestone towards AI based cardiac screening in Nature. doi.org/10.1038/s41586…
EchoNext outperformed cardiologists and found thousands of high-risk patients missed in routine care. We also made a version available to the world.
Carolyn Lam (@lamcardio) 's Twitter Profile Photo

Very pleased to share our review on AI echocardiography in cardiovascular disease management is now published! I hope this article serves as a resource for continued learning, discussion, and collaboration across the field. 🔗nature.com/articles/s4156…

Very pleased to share our review on AI echocardiography in cardiovascular disease management is now published!

I hope this article serves as a resource for continued learning, discussion, and collaboration across the field.
🔗nature.com/articles/s4156…
Niklas Dyrby Johansen (@niklasdj1) 's Twitter Profile Photo

The countdown is on! DANFLU-2 will be presented at #ESCCongress on Saturday! 332,438 adults ≥65 years 👵👴 High-dose vs standard-dose influenza vaccine 💉 Severe outcomes: hospitalizations and deaths 🏥☠️ Design paper: bit.ly/47P65ZE Look out for simpubs! 👀

The countdown is on! DANFLU-2 will be presented at #ESCCongress on Saturday!

332,438 adults ≥65 years 👵👴
High-dose vs standard-dose influenza vaccine 💉 
Severe outcomes: hospitalizations and deaths 🏥☠️

Design paper: bit.ly/47P65ZE

Look out for simpubs! 👀
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

In a large individually randomized trial embedded in routine care across a national U.S. health system, a cardiovascular-focused nudge intervention did not increase influenza vaccination rates on a background of low-uptake. Full trial results: eviden.cc/4mo2PZP #ESCCongress

In a large individually randomized trial embedded in routine care across a national U.S. health system, a cardiovascular-focused nudge intervention did not increase influenza vaccination rates on a background of low-uptake. Full trial results: eviden.cc/4mo2PZP #ESCCongress